|
Original Investigation
Use and Cost of First-Line Biologic Medications to Treat Plaque Psoriasis in the US
Benjamin N. Rome, MD, MPH; Jihye Han, PharmD, MPH; Helen Mooney, MPH; et al.
Podcast: Use of and Cost of First-Line Biologics to Treat Plaque Psoriasis in the US
Special Communication
Digital Photography Guide for Dermatologists With Special Considerations for Diverse Populations
Madison Grinnell, MD; Arielle Carolina Mora Hurtado, BS; Rick Guidotti; et al.
Earn CME credit
Images in Dermatology
Congenital Erythropoietic Porphyria
Alba Álvarez-Abella, MD; Andrea Núñez-Conde, MD; Marco A. Alba, MD
Earn CME credit
JAMA Dermatology Clinicopathological Challenge
Recurring Papules and Nodules on the Vulva
Kaila G. Moore, BS; Jayson R. Miedema, MD; Sarah B. Corley, MD, MS
Earn CME credit
JAMA Dermatology Patient Page
What Is Scleroderma?
Brook Abegaze, BS; Anna Haemel, MD
Research Letter
IL-5 Inhibitor Treatment in Drug Reaction With Eosinophilia and Systemic Symptoms
Baraa Hijaz, BS; Vinod E. Nambudiri, MD, MPH, MBA, EdM; Sotonye Imadojemu, MD, MBE, MPH
From JAMA This Week
CONSORT 2025 Statement
Sally Hopewell, DPhil; An-Wen Chan, MD, DPhil; Gary S. Collins, PhD; et al
Audio
Use of and Cost of First-Line Biologics to Treat Plaque Psoriasis in the US
|
